
Associate Principal Scientist, Regulatory Affairs
Merck
Summary
This Associate Principal Scientist position is equivalent to an Associate Director position. Under direction from Director/Executive Director, the Associate Principal Scientist is responsible for implementing Chemistry, Manufacturing, and Controls (CMC) regulatory strategies for our organization's biologics product franchises in accordance with domestic and international regulations and guidance. The Associate Principal Scientist is responsible for the preparation and submission of CMC sections for commercial or new biologics products. The Associate Principal Scientist will assist in the development and the implementation of internal regulatory strategies and provides mentoring and coaching to Senior Scientist / Scientist in support of their assigned projects.
Job description
Responsibilities
- Participation in the authorization process to prioritize submissions.
- In-depth knowledge of global Chemistry, Manufacturing, and Controls regulatory guidelines regarding Investigational New Drug Applications, Biologics License Applications, and post-approval changes.
- Completion of detailed, global regulatory assessments according to existing global guidelines and policies and defined timelines.
- Development and execution of detailed, global regulatory strategies for submission and approval of Investigational New Drug Applications, Biologics License Applications, and post-approval change documentation according to defined timelines.
- Careful planning, tracking and communicating regarding submissions and approvals to support continued product supply.
- Lead authoring of clear, concise, and effective Clinical Trial Applications, Investigational New Drug Applications, Biologics License Applications, and global post-approval submissions according to defined timelines.
- Collaborate with partner groups in the authoring and reviewing process to ensure compliance, scientific excellence, accuracy and completeness of submissions.
- Resolve project issues through collaboration with the team and escalation to the CMC leadership team as appropriate.
- Participation in early and late development programs, as well as departmental and cross-functional efforts to improve CMC content or processes may also be required, as needed.
Education Minimum Requirement
B.S. in a science, engineering, or a related field (advanced degree preferred). Fields of study include Chemical Engineering, Biology, Microbiology, Virology, Molecular Biology, or Biochemistry.
Required Experience and Skills
- Prior Biologics Investigational New Drug Application (IND), License Application (BLA) and/or post approval filing experience with at least 10 years subject matter expertise in biologics Chemistry, Manufacturing, and Controls development or manufacturing.
- Experience in biologics regulatory Chemistry, Manufacturing and Control in both pre-approval and registration required, with experience authoring agency interactions, responses to questions, and Investigational New Drug Application, Investigational Medicinal Product Dossier, and Biologics License Application sections.
- Demonstrated sound understanding of related fields (e.g., manufacturing, process development, analytical, quality assurance) and the ability to be creative and imaginative in the approach to new and complex problem solving.
- Proven experience in critically reviewing detailed scientific information and assessing whether technical arguments are presented clearly and conclusions are adequately supported by data.
- Demonstrated superior oral and written communication skills in multicultural settings and ability to communicate complex issues in a succinct and logical manner.
- Demonstrated flexibility in responding to changing priorities or dealing with unexpected events.
- Demonstrated effective leadership, project management, communication, interpersonal and negotiating skills.
- Demonstrated ability to generate innovative solutions to complex regulatory problems and effectively work with and communicate to key stakeholders.
Preferred Experience and Skills
- Experience with antibody-drug conjugates (ADCs), combination products and/or complex dosage forms through to commercialization.
- Preferred fields of study include Microbiology, Virology, Molecular Biology, Engineering or Biochemistry.
Requirements
- B.S. in a science, engineering, or a related field
- At least 10 years subject matter expertise in biologics CMC development or manufacturing
- Prior Biologics IND, BLA and/or post approval filing experience
- Experience in biologics regulatory CMC in both pre-approval and registration
- Experience authoring agency interactions, responses to questions, and IND, IMPD, and BLA sections
- Sound understanding of manufacturing, process development, analytical, and quality assurance
- Proven experience critically reviewing detailed scientific information
- Superior oral and written communication skills in multicultural settings
- Flexibility in responding to changing priorities or unexpected events
- Effective leadership, project management, communication, interpersonal and negotiating skills
- Ability to generate innovative solutions to complex regulatory problems
- Experience with antibody-drug conjugates (ADCs), combination products and/or complex dosage forms (preferred)
- Advanced degree (preferred)
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.